Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 avr. 2024 07h15 HE | Source: Bernstein Liebhard LLP

SHOALS TECHNOLOGIES GROUP, INC. (NASDAQ: SHLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Shoals Technologies Group, Inc. Investors of Upcoming Deadline

Bernstein Liebhard LLP Reminds Shoals Technologies Group, Inc. Investors of Upcoming Deadline
22 avr. 2024 10h23 HE | Source: Lowey Dannenberg, P.C.

Lowey Dannenberg Notifies Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (NASDAQ: SHLS) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
22 avr. 2024 01h45 HE | Source: Bernstein Liebhard LLP

SHOALS TECHNOLOGIES GROUP, INC. (NASDAQ: SHLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Shoals Technologies Group, Inc. Investors of Upcoming Deadline

Bernstein Liebhard LLP Reminds Shoals Technologies Group, Inc. Investors of Upcoming Deadline
19 avr. 2024 10h05 HE | Source: Lowey Dannenberg, P.C.

Lowey Dannenberg Notifies Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (NASDAQ: SHLS) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
19 avr. 2024 07h35 HE | Source: Research and Markets

Natural Killer (NK) Cell Therapy Pipeline Research Report 2024: Comprehensive Insights About 100+ Companies and 185+ Pipeline Drugs

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) cell therapy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Natural Killer...
18 avr. 2024 09h00 HE | Source: Oncternal Therapeutics

Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today...
15 avr. 2024 11h15 HE | Source: Bernstein Liebhard LLP

SHOALS TECHNOLOGIES GROUP, INC. (NASDAQ: SHLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Shoals Technologies Group, Inc.

SHOALS TECHNOLOGIES GROUP, INC. (NASDAQ: SHLS) DEADLINE ALERT
15 avr. 2024 10h45 HE | Source: Lowey Dannenberg, P.C.

Lowey Dannenberg Notifies Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (NASDAQ: SHLS) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
11 avr. 2024 06h32 HE | Source: NYI

GIX Partners with NYI at 60 Hudson Street to Launch First Fiber Route via Port Authority PATH Tunnel

GIX Partners with NYI at 60 Hudson Street to Launch First Fiber Route via Port Authority PATH Tunnel, connecting Lower Manhattan and Northern New Jersey.
03 avr. 2024 05h15 HE | Source: Research and Markets

Oligonucleotides Global Markets Report 2023-2024 & 2028: Competitive Landscape, Patent Analysis, M&A Analysis, Funding Outlook, Industry Structure

Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotides: Global Markets" report has been added to ResearchAndMarkets.com's offering. The Global Oligonucleotides Market was valued at USD...

Page précédente